Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: Metronidazole 2% Gel Versus Clindamycin 1% Gel for Moderate Acne Vulgaris [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing topical metronidazole 2% gel with clindamycin 1% gel for moderate acne vulgaris is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin 1% gel (clindamycin)
  • Metronidazole 2% gel (metronidazole)

Snippet

Sponsor: Jinnah Postgraduate Medical Centre | Conditions: Acne Vulgaris | Phase 4 | Status: NOT_YET_RECRUITING